Xvivo Perfusion AB (publ)
XVIPY · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $323 | $316 | $416 | $450 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $181 | $185 | $117 | $188 |
| Inventory | $269 | $226 | $227 | $190 |
| Other Curr. Assets | $0 | $0 | $53 | $0 |
| Total Curr. Assets | $773 | $726 | $813 | $828 |
| Property Plant & Equip (Net) | $178 | $152 | $149 | $122 |
| Goodwill | $628 | $637 | $682 | $598 |
| Intangibles | $42 | $44 | $49 | $688 |
| Long-Term Investments | $0 | $33 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $767 | $704 | $709 | $43 |
| Total NC Assets | $1,614 | $1,569 | $1,590 | $1,450 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,387 | $2,295 | $2,403 | $2,278 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $39 | $141 |
| Short-Term Debt | $8 | $9 | $11 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $153 | $131 | $127 | $10 |
| Total Curr. Liab. | $161 | $140 | $178 | $151 |
| LT Debt | $103 | $20 | $23 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $32 | $43 | $45 | $44 |
| Total NC Liab. | $135 | $63 | $68 | $44 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $111 | $29 | $34 | $0 |
| Total Liabilities | $295 | $203 | $246 | $195 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $281 | $279 | $292 | $255 |
| AOCI | $33 | $40 | $92 | $0 |
| Other Equity | $1,777 | $1,773 | $1,772 | $1,827 |
| Total Equity | $2,092 | $2,092 | $2,157 | $2,083 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,387 | $2,295 | $2,403 | $2,278 |
| Net Debt | -$212 | -$287 | -$381 | -$450 |